Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging

John C. Means, Bryan C. Gerdes, Simon Kaja, Nathalie Sumien, Andrew J. Payne, Danny A. Stark, Priscilla K. Borden, Jeffrey L. Price, Peter Koulen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Mouse models of neurodegenerative diseases such as Alzheimer’s disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.

Original languageEnglish
Pages (from-to)2278-2288
Number of pages11
JournalNeurochemical Research
Volume41
Issue number9
DOIs
StatePublished - 1 Sep 2016

Fingerprint

Neurofibrillary Tangles
Caspases
Caspase 3
Alzheimer Disease
Aging of materials
Tauopathies
tau Proteins
Molecular Models
Translational Medical Research
Structural Models
Brain Diseases
Agglomeration
Molecular Structure
Neurodegenerative Diseases
Neurodegenerative diseases
Cognition
Cognitive Dysfunction
Brain
Research

Keywords

  • Age-related cognitive decline
  • Molecular mechanisms in brain aging
  • Neurofibrillary tangles
  • Preclinical
  • Tauopathy

Cite this

Means, John C. ; Gerdes, Bryan C. ; Kaja, Simon ; Sumien, Nathalie ; Payne, Andrew J. ; Stark, Danny A. ; Borden, Priscilla K. ; Price, Jeffrey L. ; Koulen, Peter. / Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging. In: Neurochemical Research. 2016 ; Vol. 41, No. 9. pp. 2278-2288.
@article{775ab40d4c6e4b15adca92f80437d7d7,
title = "Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging",
abstract = "Mouse models of neurodegenerative diseases such as Alzheimer’s disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.",
keywords = "Age-related cognitive decline, Molecular mechanisms in brain aging, Neurofibrillary tangles, Preclinical, Tauopathy",
author = "Means, {John C.} and Gerdes, {Bryan C.} and Simon Kaja and Nathalie Sumien and Payne, {Andrew J.} and Stark, {Danny A.} and Borden, {Priscilla K.} and Price, {Jeffrey L.} and Peter Koulen",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s11064-016-1942-9",
language = "English",
volume = "41",
pages = "2278--2288",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "9",

}

Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging. / Means, John C.; Gerdes, Bryan C.; Kaja, Simon; Sumien, Nathalie; Payne, Andrew J.; Stark, Danny A.; Borden, Priscilla K.; Price, Jeffrey L.; Koulen, Peter.

In: Neurochemical Research, Vol. 41, No. 9, 01.09.2016, p. 2278-2288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging

AU - Means, John C.

AU - Gerdes, Bryan C.

AU - Kaja, Simon

AU - Sumien, Nathalie

AU - Payne, Andrew J.

AU - Stark, Danny A.

AU - Borden, Priscilla K.

AU - Price, Jeffrey L.

AU - Koulen, Peter

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Mouse models of neurodegenerative diseases such as Alzheimer’s disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.

AB - Mouse models of neurodegenerative diseases such as Alzheimer’s disease (AD) are important for understanding how pathological signaling cascades change neural circuitry and with time interrupt cognitive function. Here, we introduce a non-genetic preclinical model for aging and show that it exhibits cleaved tau protein, active caspases and neurofibrillary tangles, hallmarks of AD, causing behavioral deficits measuring cognitive impairment. To our knowledge this is the first report of a non-transgenic, non-interventional mouse model displaying structural, functional and molecular aging deficits associated with AD and other tauopathies in humans with potentially high impact on both new basic research into pathogenic mechanisms and new translational research efforts. Tau aggregation is a hallmark of tauopathies, including AD. Recent studies have indicated that cleavage of tau plays an important role in both tau aggregation and disease. In this study we use wild type mice as a model for normal aging and resulting age-related cognitive impairment. We provide evidence that aged mice have increased levels of activated caspases, which significantly correlates with increased levels of truncated tau and formation of neurofibrillary tangles. In addition, cognitive decline was significantly correlated with increased levels of caspase activity and tau truncated by caspase-3. Experimentally induced inhibition of caspases prevented this proteolytic cleavage of tau and the associated formation of neurofibrillary tangles. Our study shows the strength of using a non-transgenic model to study structure, function and molecular mechanisms in aging and age related diseases of the brain.

KW - Age-related cognitive decline

KW - Molecular mechanisms in brain aging

KW - Neurofibrillary tangles

KW - Preclinical

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=84970016708&partnerID=8YFLogxK

U2 - 10.1007/s11064-016-1942-9

DO - 10.1007/s11064-016-1942-9

M3 - Article

C2 - 27220334

AN - SCOPUS:84970016708

VL - 41

SP - 2278

EP - 2288

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 9

ER -